Stenocare AS (STENO) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.319x

Based on the latest financial reports, Stenocare AS (STENO) has a cash flow conversion efficiency ratio of -0.319x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-3.02 Million ≈ $-471.99K USD) by net assets (Dkr9.47 Million ≈ $1.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Stenocare AS - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Stenocare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read STENO liabilities breakdown for a breakdown of total debt and financial obligations.

Stenocare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stenocare AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cazaly Resources Ltd AU:CAZ	-0.048x
Merchant House International Ltd AU:MHI	-0.197x
Enjoy S.A SN:ENJOY	-0.157x
T.M.C. Industrial Public Company Limited BK:TMC	0.011x
Pets at Home Group Plc LSE:PETS	0.110x
KWG Group Holdings Limited F:KOU	0.043x
Turbon AG F:TUR	0.056x
FATFISH GROUP LTD. F:1JU	N/A

Annual Cash Flow Conversion Efficiency for Stenocare AS (2018–2025)

The table below shows the annual cash flow conversion efficiency of Stenocare AS from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Stenocare AS stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr9.47 Million ≈ $1.48 Million	Dkr-7.21 Million ≈ $-1.13 Million	-0.762x	-137.05%
2024-12-31	Dkr-3.47 Million ≈ $-543.48K	Dkr-7.14 Million ≈ $-1.12 Million	2.056x	+628.68%
2023-12-31	Dkr25.82 Million ≈ $4.04 Million	Dkr-10.04 Million ≈ $-1.57 Million	-0.389x	+37.55%
2022-12-31	Dkr24.14 Million ≈ $3.78 Million	Dkr-15.03 Million ≈ $-2.35 Million	-0.623x	-87.79%
2021-12-31	Dkr40.24 Million ≈ $6.30 Million	Dkr-13.34 Million ≈ $-2.09 Million	-0.332x	-37.22%
2020-12-31	Dkr52.57 Million ≈ $8.23 Million	Dkr-12.70 Million ≈ $-1.99 Million	-0.242x	-27.96%
2019-12-31	Dkr13.47 Million ≈ $2.11 Million	Dkr-2.54 Million ≈ $-398.12K	-0.189x	+30.65%
2018-12-31	Dkr20.47 Million ≈ $3.20 Million	Dkr-5.57 Million ≈ $-872.16K	-0.272x	--

About Stenocare AS

CO:STENO Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$10.00 Million

Dkr63.93 Million DKK

Market Cap Rank

#26863 Global

#125 in Denmark

Share Price

Dkr1.48

Change (1 day)

+7.25%

52-Week Range

Dkr0.36 - Dkr2.72

All Time High

Dkr37.18